Viewing Study NCT06236269


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2025-12-25 @ 8:41 PM
Study NCT ID: NCT06236269
Status: RECRUITING
Last Update Posted: 2024-07-19
First Post: 2023-12-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
Sponsor: SOLTI Breast Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module